Mosaic® Mitral Heart Valve with Cinch® Implant System
A third generation stented bioprosthesis with native porcine leaflets, the Mosaic Mitral Heart Valve is the solution for your patients requiring mitral valve replacement. Medtronic's innovative AOA® tissue treatment mitigates calcification, while Physiologic Fixation maintains leaflet form and function. The Cinch Implant System facilitates tying behind the stent posts.
- A third generation stented bioprosthesis
- Valve features a low profile with flexible stent posts
- AOA tissue treatment is designed to mitigate calcification, while Physiologic Fixation maintains the natural leaflet form and function.
Important Safety Information
Adverse events potentially associated with the use of bioprosthetic heart valves include: angina, cardiac arrhythmia, cardiac dysrhythmias, death, endocarditis, heart failure, hemolysis, hemolytic, anemia, hemorrhage (anticoagulant/antiplatelet-related), leak (transvalvular or paravalvular), myocardial infarction, nonstructural dysfunction (obstructive pannus ingrowth, suture dehiscence, inappropriate sizing, other), stroke, structural deterioration (calcification, leaflet tear, other), thromboembolism, valve thrombosis. It is possible that these complications could lead to: reoperation, explantation, permanent disability, or death.
No clinical data are available which evaluate the long-term impact of the Physiological Fixation process or AOA tissue treament in patients.
Please ask your Medtronic Sales Representative if this product is available in your geography.
